This strategy would be particularly important in diabetic kidney diseases, in which the role of DUSP1 has also been identified by in vivo experiments,26 and direct modification of DUSP1 may reduce inflammatory injury while avoiding the metabolic side effects of glucocorticoids. The gene discussed is DUSP1; the disease is diabetic kidney disease.